The purpose of this communication is to report our experience concerning the variation in cloning efficiency and transformation frequency utilizing C3H/10T 1/2 CL8 cells with 23 different lots of fetal bovine sera. These sera were purchased from five different commercial sources. The standard cell transformation assay using 1,000 cells per dish and 3-methylcholanthrene (7.5 micrograms/ml) as the transforming agent was performed. The chemical exposure period was 3 days. The cloning efficiency was determined in parallel toxicity tests using 200 cells per dish. Only three out of 23 serum lots supported a strong response in cell transformation. The results indicated that variation in the ability of sera to support cell transformation was not supplier dependent. In addition, our results showed that serum lots exhibiting the best cloning efficiencies did not necessarily support cell transformation. It is apparent that reliance on cloning efficiency alone would be inadequate as a means of selecting a serum lot. We therefore recommend that a complete cell transformation assay be performed when selecting fetal bovine serum for use in this assay.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/em.2860040508 | DOI Listing |
Sci Adv
January 2025
Department of Molecular Biology and Microbiology, Tufts University, Boston, MA 02111, USA.
The Epstein-Barr virus (EBV) infects nearly 90% of adults globally and is linked to over 200,000 annual cancer cases. Immunocompromised individuals from conditions such as primary immune disorders, HIV, or posttransplant immunosuppressive therapies are particularly vulnerable because of EBV's transformative capability. EBV remodels B cell metabolism to support energy, biosynthetic precursors, and redox equivalents necessary for transformation.
View Article and Find Full Text PDFPLoS One
January 2025
Molecular Virology Labs, Department of Biosciences, Comsats University Islamabad, Islamabad, Pakistan.
Arsenic-resistant Klebsiella oxytoca strain AT-02 was isolated from the ground water of the Multan region of Pakistan. The strain displayed high arsenite and arsenate resistance as minimal inhibitory concentration (MIC) was 600ppm and 10,000ppm respectively. The high tolerance of the isolated strain towards arsenate can be postulated due to significant increase in biofilm in response to arsenate.
View Article and Find Full Text PDFACS Appl Mater Interfaces
January 2025
School of Computation, Information and Technology, Technical University of Munich, Garching 85748, Germany.
Two-dimensional layered materials (2DLMs) have received increasing attention for their potential in bioelectronics due to their favorable electrical, optical, and mechanical properties. The transformation of the planar structures of 2DLMs into complex 3D shapes is a key strategic step toward creating conformal biointerfaces with cells and applying them as scaffolds to simultaneously guide their growth to tissues and enable integrated bioelectronic monitoring. Using a strain-engineered self-foldable bilayer, we demonstrate the facile formation of predetermined 3D microstructures of 2DLMs with controllable curvatures, called microrolls.
View Article and Find Full Text PDFAppl Microbiol Biotechnol
January 2025
School of Environmental and Life Sciences, The University of Newcastle, Callaghan, NSW, 2308, Australia.
The rapid advancement of nanotechnology, particularly in the realm of pharmaceutical sciences, has significantly transformed the potential for treating life-threatening diseases. A pivotal aspect of this evolution is the emergence of "green nanotechnology," which emphasizes the environmentally sustainable synthesis of raw materials through biological processes. This review focuses on the biological synthesis and application of zinc oxide (ZnO) nanoparticles (NPs) from probiotic bacteria, particularly those sourced from wastewater.
View Article and Find Full Text PDFEur J Nucl Med Mol Imaging
January 2025
Departments of Radiology and Medical Physics, University of Wisconsin - Madison, Madison, WI, 53705, USA.
Purpose: Trophoblast cell-surface antigen 2 (Trop2) is overexpressed in various solid tumors and contributes to tumor progression, while its expression remains low in normal tissues. Trop2-targeting antibody-drug conjugate (ADC), sacituzumab govitecan-hziy (Trodelvy), has shown efficacy in targeting this antigen. Leveraging the enhanced specificity of ADCs, we conducted the first immunoPET imaging study of Trop2 expression in gastric cancer (GC) and triple-negative breast cancer (TNBC) models using Zr-labeled Trodelvy ([Zr]Zr-DFO-Trodelvy).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!